Home › Funds › Ishara Investments LP › SLN

Ishara Investments LP position in SLN

SILENCE THERAPEUTICS PLC · Health Care

Ishara Investments LP reported holding 160,000 shares of SLN (SILENCE THERAPEUTICS PLC) in its Q3 2026 13F filing — a position valued at US$1.7M, representing 1.47% of its reported portfolio and ranking #25 among its reported holdings. Ishara Investments LP has disclosed SLN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)160.00K sh
Reported value held$1.75M
Portfolio Weight1.47%
First reportedQ4 2025
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Ishara Investments LP's SLN position evolved

Ishara Investments LP first disclosed a stake in SLN in Q4 2025 at 240,000 shares (US$1.5M). The position peaked in Q2 2026 at 55,350 shares, worth US$2.4M. Across 4 filings, Ishara Investments LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 160,000 shares valued at US$1.7M — an increase of 104,650 shares quarter over quarter.. Notable position changes include a 41% trim in Q1 2026 (shares rose 108% over the following quarter), a 61% trim in Q2 2026 (shares were roughly flat over the following quarter), a 189% increase in Q3 2026 (shares rose 81% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 240.00K $1.46M New
Q1 2026 140.50K $740.43K Reduce
Q2 2026 55.35K $2.43M Reduce
Q3 2026 160.00K $1.75M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SLN and 13F data

SLN (SILENCE THERAPEUTICS PLC) is a Health Care company. 43 other funds we track also report a position in SLN — the largest reported positions include Siren, L.L.C. (US$31.6M), Redmile Group, LLC (US$23.8M), TCG Crossover Management, LLC (US$19.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SLN

All SLN fund holders →

FAQ

How long has Ishara Investments LP held SLN?

Ishara Investments LP has disclosed SLN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Ishara Investments LP's current position in SLN?

As of Q3 2026, Ishara Investments LP holds 160.00K shares of SLN (SILENCE THERAPEUTICS PLC), valued at $1.75M, representing 1.47% of its reported portfolio and ranking #25.

Has Ishara Investments LP been buying or selling SLN?

In the latest 13F filing (Q3 2026), Ishara Investments LP increased its position in SLN. The position peaked in Q2 2026 at 55.35K shares.

Which other funds hold SLN?

Other major institutional holders of SLN include Siren, L.L.C., Redmile Group, LLC, TCG Crossover Management, LLC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.